Mahaffey, K W <br/><br/>
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.  [electronic resource] 

 -  Circulation  May 1999 
 - 2371-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.99.18.2371  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Age Factors<br/>Aged<br/>Angina, Unstable--complications<br/>Aspirin--therapeutic use<br/>Brain Damage, Chronic--epidemiology<br/>Cerebral Hemorrhage--epidemiology<br/>Cerebral Infarction--epidemiology<br/>Cerebrovascular Disorders--epidemiology<br/>Comorbidity<br/>Diabetes Mellitus--epidemiology<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Electrocardiography<br/>Eptifibatide<br/>Female<br/>Heart Rate<br/>Heparin--therapeutic use<br/>Humans<br/>Hyperlipidemias--epidemiology<br/>Hypertension--epidemiology<br/>Incidence<br/>Male<br/>Middle Aged<br/>Obesity--epidemiology<br/>Odds Ratio<br/>Peptides--therapeutic use<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Prospective Studies<br/>Recurrence<br/>Risk Factors<br/>Smoking--epidemiology<br/>Treatment Outcome